ArticleCrop health2026
Expression and immunoassay application of full-length recombinant antibody recognizing chlorantraniliprole using Pichia pastoris expression system.
Article in Crop health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Full-length recombinant antibodies (rAbs) expressed in yeast offer the advantage of a eukaryotic system ensuring proper folding and bioactivity, along with high yield and low cost. In this study, plasmids encoding the light chain and heavy chain of the anti-chlorantraniliprole monoclonal antibody (mAb) were constructed under the control of inducible alcohol oxidase promoters and equipped with secretory signal peptides. Subsequently, the rAb was expressed in Pichia pastoris and further utilized to develop a lateral flow immunoassay (LFIA). The visual limit of detection (vLOD) of the rAb-based LFIA was 0.63 ng/mL, which was twofold lower than that of the mAb-based LFIA. Validated via recovery experiments, the rAb-LFIA demonstrated that the vLOD of chlorantraniliprole in rice, apple, and grape samples complied with the maximum residue limits specified in Chinese and European Union food safety standards. Moreover, the rAb-LFIA exhibited reliability comparable to that of UPLC-MS/MS in the detection of blind samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.